Top compounds associated with response to SRI


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib gCSI pan-cancer AAC 0.022 0.7
mRNA SN-38 CTRPv2 pan-cancer AAC 0.014 0.7
mRNA Bicalutamide FIMM pan-cancer AAC -0.065 0.7
mRNA CEP-701 FIMM pan-cancer AAC -0.047 0.7
mRNA istradefylline CTRPv2 pan-cancer AAC -0.022 0.7
mRNA etoposide CTRPv2 pan-cancer AAC 0.012 0.7
mRNA ML334 diastereomer CTRPv2 pan-cancer AAC 0.017 0.7
mRNA ZSTK474 CTRPv2 pan-cancer AAC 0.014 0.7
mRNA BRD-K11533227 CTRPv2 pan-cancer AAC -0.014 0.7
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.7
Download CSV